TY - JOUR
T1 - Positron emission tomography scanning in essential blepharospasm
AU - Kerrison, John B.
AU - Lancaster, Jack L.
AU - Zamarripa, Frank E.
AU - Richardson, Londe A.
AU - Morrison, John C.
AU - Holck, David E.E.
AU - Andreason, Kurt W.
AU - Blaydon, Sean M.
AU - Fox, Peter T.
N1 - Funding Information:
Supported by a grant (FWH20010122H) from the Office of the Surgeon General of the United States Air Force. The features expressed in the article are those of the authors and do not reflect the official policy of the Department of Defense or other departments of the United States government.
PY - 2003/11
Y1 - 2003/11
N2 - PURPOSE: To localize in the brain using positron emission tomography neuroimaging with 18fluorodeoxyglucose [PET (18FDG)] differences in glucose metabolism between patients with essential blepharospasm (EB) and controls. DESIGN: Prospective case-control study. METHODS: Positron emission tomography neuroimaging with 18fluorodeoxyglucose was performed in 11 patients with EB and 11 controls matched for age and gender. Global analysis of images was used to localize differences in glucose metabolism between groups. RESULTS: Multiple cortical and subcortical abnormalities were observed in EB patients in comparison with controls. Cortical areas with the largest and most significant clusters of increased glucose uptake were the inferior frontal gyri, right posterior cingulate gyrus, left middle occipital gyrus, fusiform gyrus of the right temporal lobe, and left anterior cingulate gyrus. Cortical areas with the largest and most significant clusters of decreased glucose uptake were the inferior frontal gyri, ventral to the area of increased glucose metabolism. Subcortical abnormalities, consisting of increased glucose uptake, involved the right caudate and consisting of decreased glucose uptake, involved the left inferior cerebellar hemisphere and thalamus. CONCLUSIONS: Global analysis of positron emission tomography neuroimaging with 18fluorodeoxyglucose neuroimaging in EB patients in comparison with controls demonstrates a pattern of abnormalities involving several cortical and subcortical areas that control blinking, including the inferior frontal lobe, caudate, thalamus, and cerebellum.
AB - PURPOSE: To localize in the brain using positron emission tomography neuroimaging with 18fluorodeoxyglucose [PET (18FDG)] differences in glucose metabolism between patients with essential blepharospasm (EB) and controls. DESIGN: Prospective case-control study. METHODS: Positron emission tomography neuroimaging with 18fluorodeoxyglucose was performed in 11 patients with EB and 11 controls matched for age and gender. Global analysis of images was used to localize differences in glucose metabolism between groups. RESULTS: Multiple cortical and subcortical abnormalities were observed in EB patients in comparison with controls. Cortical areas with the largest and most significant clusters of increased glucose uptake were the inferior frontal gyri, right posterior cingulate gyrus, left middle occipital gyrus, fusiform gyrus of the right temporal lobe, and left anterior cingulate gyrus. Cortical areas with the largest and most significant clusters of decreased glucose uptake were the inferior frontal gyri, ventral to the area of increased glucose metabolism. Subcortical abnormalities, consisting of increased glucose uptake, involved the right caudate and consisting of decreased glucose uptake, involved the left inferior cerebellar hemisphere and thalamus. CONCLUSIONS: Global analysis of positron emission tomography neuroimaging with 18fluorodeoxyglucose neuroimaging in EB patients in comparison with controls demonstrates a pattern of abnormalities involving several cortical and subcortical areas that control blinking, including the inferior frontal lobe, caudate, thalamus, and cerebellum.
UR - http://www.scopus.com/inward/record.url?scp=0142257971&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0142257971&partnerID=8YFLogxK
U2 - 10.1016/S0002-9394(03)00895-X
DO - 10.1016/S0002-9394(03)00895-X
M3 - Article
C2 - 14597035
AN - SCOPUS:0142257971
SN - 0002-9394
VL - 136
SP - 846
EP - 852
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
IS - 5
ER -